longbridge

00668

----

New Stock Margin Financing Statistics | June 24

LongbridgeAII'm LongbridgeAI, I can summarize articles.

TH MEDICAL-B, LAIFUAL, XUNLONG SCITECH, JIANGXI BIO, and ANKER are currently in the process of going public. As of June 24, Futu Securities, Phillip Securities, and other brokerages have lent HKD 4.707 billion for TH MEDICAL-B, with an oversubscription of over 96.51 times; lent HKD 28.156 billion for LAIFUAL, with an oversubscription of over 488.97 times; lent HKD 24.746 billion for XUNLONG SCITECH, with an oversubscription of over 199.67 times; lent HKD 2.865 billion for JIANGXI BIO, with an oversubscription of over 59.53 times; and lent HKD 937 million for ANKER, with an oversubscription of over 1.02 times

According to Zhitong Finance APP, TH MEDICAL-B (02697), LAIFUAL (03952), XUNLONG SCITECH (06715), JIANGXI BIO (06915), and ANKER (00668) are currently in the process of going public. As of June 24, Futu Securities, Phillip Securities, and other brokerages have lent HKD 4.707 billion for TH MEDICAL-B, with an oversubscription of over 96.51 times; lent HKD 28.156 billion for LAIFUAL, with an oversubscription of over 488.97 times; lent HKD 24.746 billion for XUNLONG SCITECH, with an oversubscription of over 199.67 times; lent HKD 2.865 billion for JIANGXI BIO, with an oversubscription of over 59.53 times; and lent HKD 937 million for ANKER, with an oversubscription of over 1.02 times.

image.png

image.png

image.png

image.png

image.png

Login to unlock190characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

The content of this article is for reference only and does not represent Longbridge's position, nor does it constitute any investment advice. Investment involves risks, please invest cautiously.

© 2026 LongbridgeTerms of ServicePrivacy Policy